Abhinav A. Shukla sold $2,874 of STTK
Chief Technical Officer at Shattuck Labs, Inc.. 410 shares at an average of $7.01, traded Jul 2, 2026, filed Jul 7, 2026.
Score components
- +15RoleOfficer
- 0Trade size$3k at market
- 0Share of holdings soldSold 0.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-297768, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | MOption exercise Common Stock10b5-1 | +410 | $3.57 | $1,464 | 86,790 | Jul 7, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock10b5-1 | -410 | $7.01 | $2,874 | 86,380 | Jul 7, 2026 |
| Jul 6, 2026 | MOption exercise Common Stock10b5-1 | +12,153 | $3.57 | $43k | 98,533 | Jul 7, 2026 |
| Jul 2, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -410 | $0.00 | $0 | 26,293 | Jul 7, 2026 |
| Jul 6, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,153 | $0.00 | $0 | 14,140 | Jul 7, 2026 |
Related signals
Other insiders at Shattuck Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | Shattuck Labs, Inc. | Arundathy N. Pandite Chief Medical Officer | $210k 30,000 shares | -18% | |
| 4Weak | Shattuck Labs, Inc. | Abhinav A. Shukla Chief Technical Officer | $166k 23,465 shares | -21% | |
| 42Moderate | STTKbuy Shattuck Labs, Inc. | Clay B Siegall director | $250k 62,500 shares | +24% | |
| 20Weak | Shattuck Labs, Inc. | Arundathy N. Pandite Chief Medical Officer | $198k 30,000 shares | -15% | |
| 0Weak | Shattuck Labs, Inc. | Abhinav A. Shukla Chief Technical Officer | $14k 2,032 shares | -2% | |
| 64Notable | Shattuck Labs, Inc. | Mona Ashiya director | $5.5M 6,306,127 shares | - | |
| 64Notable | Shattuck Labs, Inc. | Orbimed Advisors LLC director | $5.5M 6,306,127 shares | - | |
| 26Weak | STTKbuy Shattuck Labs, Inc. | Redmile Group, LLC director, owner | $167k 133,371 shares | +2% | |
| 26Weak | STTKsell Shattuck Labs, Inc. | Redmile Group, LLC director, owner | $167k 133,371 shares | -2% | |
| 0Weak | Shattuck Labs, Inc. | Stephen Stout See Remarks | $169k 16,004 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.